Molina Healthcare Stock: A Deep Dive Into Analyst Perspectives (11 Ratings)
Portfolio Pulse from Benzinga Insights
In the last three months, 11 analysts have provided diverse ratings on Molina Healthcare (NYSE:MOH), with a shift towards more neutral positions. The average 12-month price target has increased to $425.18 from $412.17. Analyst actions include adjustments to ratings and price targets, reflecting responses to market conditions and company performance. Molina Healthcare's financial health shows positive revenue growth, impressive net margin, ROE, and ROA, but a high debt-to-equity ratio. The company specializes in Medicaid-related healthcare plans.
April 25, 2024 | 7:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Analyst ratings for Molina Healthcare show a trend towards neutrality with an updated average price target of $425.18, indicating a positive outlook. The company's strong financial performance and positive revenue growth are highlighted, despite a high debt-to-equity ratio.
The shift in analyst ratings towards a more neutral stance, combined with an increase in the average price target, suggests a cautiously optimistic outlook for MOH. The company's strong financial indicators, such as revenue growth and net margin, support a positive short-term impact. However, the high debt-to-equity ratio is a concern that might temper bullish sentiment, hence the score reflects a balanced view considering both positive and negative factors.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100